Highlights from the 2025 Muscular Dystrophy Association (MDA) Conference include clinical updates, expert insights, and breaking trial findings.

THURSDAY, Oct. 23, 2025 (HealthDay News) — Autoimmune neuromuscular diseases may sound complex, but understanding them is the first step to getting the right care and support. Conditions such as Lambert-Eaton myasthenic syndrome (LEMS), myasthenia gravis ...

A team of researchers has developed a promising new approach to detecting neuromuscular disorders using intramuscular electromyography (iEMG). In a pilot study, the automatic diagnostic system showed high accuracy in three ... In the era of "publish or ...

The rare disorder Kennedy’s disease leads to progressively worsening muscle weakness in the limbs as well as difficulty speaking and swallowing. There are no FDA-approved treatments for the inherited neuromuscular disorder, but the scientists at Nido ...

Jeffrey Del Carmen, Chief Commercial Officer of Catalyst Pharmaceuticals ( CPRX +0.06%), exercised and immediately sold 10,983 shares of common stock on November 26, 2025, for a total value of approximately $256,200, as disclosed in this SEC Form 4 filing. Transaction value based on SEC Form 4 weighted average purchase price ($23.33).